Epidermal growth factor receptor mutations in non-small cell lung cancer: a basic science discovery with immediate clinical impact

The American Journal of the Medical Sciences
Jonathan E Dowell

Abstract

A large body of preclinical work suggested that the epidermal growth factor receptor (EGFR) would be a successful target for therapy against non-small cell lung cancer (NSCLC), and this led to the development of oral, selective EGFR tyrosine kinase inhibitors (TKI) that improve symptoms and survival in patients with advanced NSCLC. However, not all patients benefit from this treatment, and there has been great interest in identifying the molecular correlates that predict for response to these agents. The recent detection of somatic mutations in EGFR that predict for response to the EGFR tyrosine kinase inhibitors has excited the scientific community. This discovery has far-reaching implications, not only for lung cancer patients treated with an EGFR TKI but also for future drug development in all malignancies.

References

Jul 17, 1991·Journal of the National Cancer Institute·R J SlebosS Rodenhuis
Aug 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·U PastorinoF Rilke
Jan 8, 1998·International Journal of Cancer. Journal International Du Cancer·M I KoukourakisA L Harris
May 1, 1998·American Journal of Respiratory and Critical Care Medicine·T M GreatensD E Niewoehner
Jun 13, 1998·Journal of the National Cancer Institute·J Rubin GrandisD J Tweardy
Mar 11, 1999·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·T HiraiT Toge
Mar 30, 1999·The Journal of Thoracic and Cardiovascular Surgery·T A D'AmicoD H Harpole
Apr 27, 1999·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·X L FuG L Jiang
Aug 24, 1999·Pharmacology & Therapeutics·J R Woodburn
Aug 30, 2000·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·E T HsiehM S Tsao
Jul 4, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M HidalgoE K Rowinsky
Jan 11, 2002·The New England Journal of Medicine·Joan H SchillerUNKNOWN Eastern Cooperative Oncology Group
Jan 24, 2002·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Catherine MetayerJay H Lubin
Mar 15, 2002·Seminars in Oncology·Wilbur A FranklinPaul A Bunn
May 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Malcolm RansonEric K Rowinsky
Jul 6, 2002·Science·I Bernard Weinstein
Sep 14, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roy S HerbstPatricia Mucci LoRusso
Mar 22, 2003·Experimental Cell Research·David W Fry
May 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Masahiro FukuokaJosé Baselga
May 24, 2003·The European Respiratory Journal·A P MeertJ P Sculier
Sep 4, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fred R HirschWilbur A Franklin
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giuseppe GiacconeDavid H Johnson
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roy S HerbstDavid H Johnson
Mar 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vincent A MillerRobert T Heelan
May 26, 2004·Biochemical and Biophysical Research Communications·Robert Roskoski
Jul 31, 2004·Science·Raffaella SordellaJeffrey Settleman
Aug 18, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Román Pérez-SolerPhilip Bonomi
Aug 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·William PaoHarold Varmus
Sep 30, 2004·International Journal of Cancer. Journal International Du Cancer·Jong Woo LeeSug Hyung Lee

❮ Previous
Next ❯

Citations

Oct 13, 2006·Nature Reviews. Cancer·Mukesh K NyatiTheodore S Lawrence
Jan 12, 2007·Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine·Zhen-ye Xu, Zhan Zheng
Sep 19, 2006·Annals of Diagnostic Pathology·Ludmila Prudkin, Ignacio I Wistuba
Oct 13, 2006·Gynecologic Oncology·Kathleen M Darcy, Russel J Schilder

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.